Functional connectivity underlying cognitive and psychiatric symptoms in post-COVID-19 syndrome
Functional connectivity underlying cognitive and psychiatric symptoms in post-COVID-19 syndrome
|
Loading...
Lütfen bekleyiniz...
Type
Size

İlgili Videolar

Functional connectivity underlying cognitive and psychiatric symptoms in post-COVID-19 syndrome

Functional connectivity underlying cognitive and psychiatric symptoms in post-COVID-19 syndrome

|
Post COVID Recovery - Neurocognitive Sequelae, Functional Cognition and Cognitive Communication

Post COVID Recovery - Neurocognitive Sequelae, Functional Cognition and Cognitive Communication

|
ICP webinar: Physiological and functional brain changes in adults post-COVID-19 infection

ICP webinar: Physiological and functional brain changes in adults post-COVID-19 infection

|
Alterations in the functional connectivity of monoamine circuits in cognitive fatigue in MS

Alterations in the functional connectivity of monoamine circuits in cognitive fatigue in MS

|
Severe COVID-19 cases may cause cognitive impairment equivalent to aging 20 years

Severe COVID-19 cases may cause cognitive impairment equivalent to aging 20 years

|
COVID Neuro Network: Neuropsychiatric and neurocognitive aspects in Australia and America

COVID Neuro Network: Neuropsychiatric and neurocognitive aspects in Australia and America

|
Session I–Long Covid: What Do We Know So Far? With Dr. Nisreen Alwan and Dr. Natalie Lambert

Session I–Long Covid: What Do We Know So Far? With Dr. Nisreen Alwan and Dr. Natalie Lambert

|
Webinar - Recovery from COVID-19: Coping with Physical, Cognitive and Psychological Effects

Webinar - Recovery from COVID-19: Coping with Physical, Cognitive and Psychological Effects

|
COVID-19: The State of the Literature and Clinical Implications

COVID-19: The State of the Literature and Clinical Implications

|
LONG COVID IS REAL RISK: Av. 33% AFTER INFECTION: SYMPTOMS AND CLINICAL DATA 10-23-21

LONG COVID IS REAL RISK: Av. 33% AFTER INFECTION: SYMPTOMS AND CLINICAL DATA 10-23-21

|
Cambridge Neuroscience - Lucy Cheke - Covid and Cognition

Cambridge Neuroscience - Lucy Cheke - Covid and Cognition

|
COVID PREVENTION AND MILD TO SEVERE TREATMENTS, BRAIN COGNITIVE LOSS 10-23 Clinical part 2

COVID PREVENTION AND MILD TO SEVERE TREATMENTS, BRAIN COGNITIVE LOSS 10-23 Clinical part 2

|
Surviving COVID-19: Long-Term Cognitive and Mental Health Effects on Patients and Their Caregivers

Surviving COVID-19: Long-Term Cognitive and Mental Health Effects on Patients and Their Caregivers

|
Innovations in Rehabilitation from Around the Globe-Neuropsychological Consequences of Covid-19

Innovations in Rehabilitation from Around the Globe-Neuropsychological Consequences of Covid-19

|
Pocket Talk | Managing and Preventing Delirium in Older Adults: ​Including post-COVID |​ 5/19/2023

Pocket Talk | Managing and Preventing Delirium in Older Adults: ​Including post-COVID |​ 5/19/2023

|
Brain Fog After COVID-19: What We Know and What You Can Do

Brain Fog After COVID-19: What We Know and What You Can Do

|
Understanding Long COVID: Managing Client Symptoms & Supporting Recovery - Webinar 18th March 2021

Understanding Long COVID: Managing Client Symptoms & Supporting Recovery - Webinar 18th March 2021

|
Post covid Syndrome long covid and its main signs and symptoms pathogenesis treatment options

Post covid Syndrome long covid and its main signs and symptoms pathogenesis treatment options

|
Identifying the Effects of COVID-19 on Cognitive Function and Recovery Trajectories

Identifying the Effects of COVID-19 on Cognitive Function and Recovery Trajectories

|
Post-COVID Syndrome: 1 in 10 patients suffer symptoms for 12+ weeks

Post-COVID Syndrome: 1 in 10 patients suffer symptoms for 12+ weeks

|
Copyright. All rights reserved © 2025
Rosebank, Johannesburg, South Africa